In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates

被引：12
|
作者：
Su, Jiachun [1 ,2 ]
Li, Dan [1 ,2 ]
Guo, Qinglan [1 ,2 ]
Guo, Yan [1 ,2 ]
Zheng, Yonggui [1 ,2 ]
Xu, Xiaogang [1 ,2 ,3 ]
机构：
[1] Fudan Univ, Huashan Hosp, Inst Antibiot, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China
[2] Natl Hlth & Family Planning Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
[3] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China
来源：
MICROBIAL DRUG RESISTANCE | 2019年 / 25卷 / 02期
关键词：
carbapenem-resistant Klebsiella pneumoniae; trimethoprim-sulfamethoxazole; colistin; bactericidal activity; COLISTIN; THERAPY;
D O I：
10.1089/mdr.2018.0085
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a formidable health challenge in recent years owing to the shortage of effective antibiotics. Colistin is the last and sometimes the only therapeutic option for CRKP infections. Unfortunately, resistance to colistin monotherapy is likely to develop. CRKP in China reportedly exhibit low rates of resistance to trimethoprim-sulfamethoxazole. The aim of this study was to evaluate the in vitro efficacy of trimethoprim-sulfamethoxazole in combination with colistin against four CRKP clinical isolates. The trimethoprim-sulfamethoxazole/colistin combination rapidly killed all four of the tested isolates after 2 h up to 24 h. Trimethoprim-sulfamethoxazole is one of the few remaining antimicrobials with some activity against CRKP. In particular, combined with colistin, trimethoprim-sulfamethoxazole might be promising for the treatment of CRKP infections.
引用
收藏
页码：152 / 156
页数：5
相关论文
共 50 条
  • [41] In-vitro synergistic activity of colistin and meropenem against clinical isolates of carbapenem resistant E.coli and Klebsiella pneumoniae by checkerboard method
    Dhandapani, Sarumathi
    Sistla, Sujatha
    Gunalan, Anitha
    Manoharan, Meerabai
    Sugumar, Madhan
    Sastry, Apurba Sankar
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 39 (01) : 6 - 10
  • [42] In vitro activity of zidebactam/cefepime (WCK 5222), a β-lactam enhancer/ β-lactam combination against carbapenem- and colistin-resistant Klebsiella pneumoniae isolates
    Bakthavatchalam, Yamuna Devi
    Shankar, Chaitra
    Jeyaraj, Christo
    Neeravi, Ayyanraj
    Mathur, Purva
    Nagvekar, Vasant
    Nithiyanandam, Sangeetha
    Walia, Kamini
    Veeraraghavan, Balaji
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (01)
  • [43] Antimicrobial activity of ceftibuten/polymyxin B combination against polymyxin/carbapenem-resistant Klebsiella pneumoniae
    Sturaro, Mariana Carvalho
    de Souza, Gleyce Hellen de Almeida
    Damaceno, Nathalia da Silva
    Silva, Osmar Nascimento
    de Aquino, Thiago Mendonca
    Freire, Nathalia Monteiro Lins
    Alcantara, Marcone Gomes dos Santos
    Monteiro, Kadja Luana Chagas
    Martins, Aline Andrade
    Rossato, Luana
    Fraga, Thiago Leite
    Borsuk, Sibele
    Dellagostin, Odir Antonio
    Simionatto, Simone
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 80 (01) : 116 - 125
  • [44] The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates (vol 10, 736, 2021)
    Nulsopapon, Parnrada
    Nasomsong, Worapong
    Pongchaidecha, Manat
    Changpradub, Dhitiwat
    Juntanawiwat, Piraporn
    Santimaleeworagun, Wichai
    ANTIBIOTICS-BASEL, 2022, 11 (06):
  • [45] In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii
    Song, Joon Young
    Kee, Sae Yoon
    Hwang, In Sook
    Bin Seo, Yu
    Jeong, Hye Won
    Kim, Woo Joo
    Cheong, Hee Jin
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) : 317 - 322
  • [46] In vitro activity of tigecycline against multiple resistant Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae isolates
    Akan, Oezay Arikan
    Uysal, Sevil
    MIKROBIYOLOJI BULTENI, 2008, 42 (02): : 209 - 215
  • [47] In vitro activity of cefiderocol, a siderophore cephalosporin, against carbapenem-resistant hypervirulent Klebsiella pneumoniae in China
    Zhao, Jiankang
    Pu, Danni
    Li, Ziyao
    Liu, Xinmeng
    Zhang, Yulin
    Wu, Yongli
    Zhang, Feilong
    Li, Chen
    Zhuo, Xianxia
    Lu, Binghuai
    Cao, Bin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023,
  • [48] Emergence of colistin-heteroresistant and carbapenem-resistant hypervirulent Klebsiella pneumoniae
    Wang, Tao
    Wang, Xiaojun
    Chen, Suming
    Zhu, Jie
    Zhu, Zhichen
    Qu, Fen
    Chen, Liang
    Du, Hong
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 35 : 237 - 243
  • [49] Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
    Bir, Raunak
    Gautam, Hitender
    Arif, Nazneen
    Chakravarti, Priyanka
    Verma, Jyoti
    Banerjee, Sayantan
    Tyagi, Sonu
    Mohapatra, Sarita
    Sood, Seema
    Dhawan, Benu
    Chaudhry, Rama
    Kapil, Arti
    Das, Bimal Kumar
    Das, Bhabatosh
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
  • [50] Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
    Bir, Raunak
    Gautam, Hitender
    Arif, Nazneen
    Chakravarti, Priyanka
    Verma, Jyoti
    Banerjee, Sayantan
    Tyagi, Sonu
    Mohapatra, Sarita
    Sood, Seema
    Dhawan, Benu
    Chaudhry, Rama
    Kapil, Arti
    Das, Bimal Kumar
    Das, Bhabatosh
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
12345